Laboratory Products
Fast, Accurate ID of MRSA by detecting mecA gene mRNA
Dec 12 2014
The new AdvanDx mecA XpressFISH assay, exclusively available in the UK from Alpha Laboratories, is the first and only molecular assay that detects the active resistance gene (mecA) from positive Staphylococcus aureus blood cultures.
It provides results one to three days sooner than conventional methods, allowing for early and appropriate therapy for patients with methicillin-resistant S.aureus (MRSA) and methicillin-sensitive S.aureus (MSSA) infections. Differentiation also enables de-escalation of vancomycin treatment for patients with MSSA infections.
Methicillin-resistant Staphylococcus aureus (MRSA) is one of the most common antimicrobial resistant pathogens and can lead to increased hospital costs and extra length of stay. Methicillin-resistance is almost exclusively caused by the presence and expression of the mecA gene that encodes a unique penicillin-binding protein (PBP2a) with low affinity for methicillin and other β-lactam drugs. The new mecA XpressFISH assay reliably and rapidly provides a positive identification of MRSA by confirming mecA gene expression with greater than 98% sensitivity and specificity.
mecA XpressFISH detects active transcription of the mecA gene. The protocol requires only 15 minutes hands on time and gives a result in just one hour compared to two days using conventional methods. It is based on the proven, reliable PNA-FISH technology from AdvanDX and requires no complex, expensive equipment. The kit provides the ideal companion to the QuickFISH 20 minute Staphylococcus assay that provides the initial species identification from positive blood cultures.
Please visit www.sepsis-diagnostics.co.uk/xpressfish for further information.
Digital Edition
International Labmate 49.6 - Sept 2024
September 2024
Chromatography Articles - HPLC gradient validation using non-invasive flowmeters Mass Spectrometry & Spectroscopy Articles - From R&D to QC, making NMR accessible for everyone: Putting NMR...
View all digital editions
Events
Sep 29 2024 Singapore
Oct 06 2024 Liverpool, UK
Oct 08 2024 Gothenburg, Sweden
Oct 09 2024 Birmingham, UK
Oct 09 2024 NEC, Birmingham, UK